methamphetamine has been researched along with galantamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kishimoto, K; Kitamura, Y; Minamino, H; Shibaike, T; Shimohama, S; Takata, K; Takeuchi, H; Taniguchi, T; Tsushima, J; Yanagida, T; Yasui, H | 1 |
| Ando, Y; Mouri, A; Nabeshima, T; Noda, Y; Ozaki, N; Waki, Y; Wang, D; Yamada, K; Yamada, SN; Yoshimi, A | 1 |
| Koseki, T; Mamiya, T; Mouri, A; Nabeshima, T; Nakajima, A; Suzuki, S; Yan, Y | 1 |
1 review(s) available for methamphetamine and galantamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for methamphetamine and galantamine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Functional Laterality; Galantamine; Gene Expression Regulation; Male; Mecamylamine; Methamphetamine; Motor Activity; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Rotarod Performance Test; Tyrosine 3-Monooxygenase | 2008 |
Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems.
Topics: Acetylcholine; Adrenergic Uptake Inhibitors; Animals; Cholinesterase Inhibitors; Cognition; Donepezil; Dopamine; Dopamine Agonists; Galantamine; Indans; Male; Memory; Methamphetamine; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Piperidines; Receptors, Muscarinic; Receptors, Nicotinic; Recognition, Psychology | 2010 |
Galantamine attenuates reinstatement of cue-induced methamphetamine-seeking behavior in mice.
Topics: Amphetamine-Related Disorders; Analysis of Variance; Animals; Appetitive Behavior; Central Nervous System Stimulants; Cholinesterase Inhibitors; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Galantamine; Humans; Locomotion; Methamphetamine; Mice; Nucleus Accumbens; Secondary Prevention; Self Administration | 2014 |